Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
MedCity News22h
FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.
GEN3h
Seven Biopharma Trends to Watch in 2025
GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...
Levi & Korsinsky Announces an Investigation on Behalf of Vertex Pharmaceuticals Incorporated (VRTX) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
Raymond James downgrades Vertex (VERX) to a Hold
Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s ...
Regeneron expands eye care focus with Oxular buyout
Regeneron Pharmaceuticals (REGN) expands its focus on eye care with the acquisition of Oxular, a U.K.-based biotech ...
Wall Street Journal21h
Anhui Sunhere Pharmaceutical Excipients Co. Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
MarketWatch12h
Spotify Technology S.A.
Liberty Media Corp. Series C Liberty Formula One-0.59% $28.72B Liberty Media Corp. Series A Liberty Formula One-0.83% $28.72B ...